Radioactive waste.pdf
1.5 MB
Contents and sample arguments of a safety case for near surface disposal of radioactive waste
🆔 @partohair
🆔 @partohair
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
More information👇
🆔 @partohair
More information👇
🆔 @partohair
January 4, 2018 — Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i Proton Therapy System including Hyperscan pencil beam scanning (PBS) technology. Hyperscan PBS introduces novel energy layer switching and automated collimation systems. These advantages enable the S250i system to deliver faster, sharper and more robust PBS proton radiation treatments.
The Mevion S250i system is a compact proton therapy system capable of delivering conformal radiation therapy treatments using Hyperscan pencil beam scanning technology. The design of Hyperscan PBS technology overcomes clinical challenges that were previously faced by first-generation PBS systems.
Pencil beam scanning systems shape the delivered radiation dose by “painting” tumors spot-by-spot and layer-by-layer with sub-atomic particles. Prior to Hyperscan PBS, scanning proton systems struggled with delivery speed, according to Mevion. Long delivery times can undermine the high precision of the treatment due to the target tumor shifting under normal organ motion such as breathing.
The Mevion S250i system is based on Mevion’s high-efficiency, low-financial-risk S250 Series platform. The core technology of the S250 Series is what the company calls the world’s only gantry mounted superconducting synchrocyclotron.
For more information:
https://www.itnonline.com/content/mevion-receives-510k-clearance-hyperscan-pencil-beam-scanning-proton-therapy
🆔 @partohair
The Mevion S250i system is a compact proton therapy system capable of delivering conformal radiation therapy treatments using Hyperscan pencil beam scanning technology. The design of Hyperscan PBS technology overcomes clinical challenges that were previously faced by first-generation PBS systems.
Pencil beam scanning systems shape the delivered radiation dose by “painting” tumors spot-by-spot and layer-by-layer with sub-atomic particles. Prior to Hyperscan PBS, scanning proton systems struggled with delivery speed, according to Mevion. Long delivery times can undermine the high precision of the treatment due to the target tumor shifting under normal organ motion such as breathing.
The Mevion S250i system is based on Mevion’s high-efficiency, low-financial-risk S250 Series platform. The core technology of the S250 Series is what the company calls the world’s only gantry mounted superconducting synchrocyclotron.
For more information:
https://www.itnonline.com/content/mevion-receives-510k-clearance-hyperscan-pencil-beam-scanning-proton-therapy
🆔 @partohair
Imaging Technology News
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i Proton Therapy System including Hyperscan pencil beam scanning (PBS) technology. Hyperscan PBS introduces novel energy layer switching and automated…
ICRU 72 .pdf
3.6 MB
ICRU report No.72
Dosimetry of beta rays and Low-energy photons for Brachytherapy with sealed sources
🆔 @partohair
Dosimetry of beta rays and Low-energy photons for Brachytherapy with sealed sources
🆔 @partohair
🔺 "در تمام طول عُمرم با تهدید مرگ زودرس زندگی کرده ام، برای همین است از اتلاف وقت بیزارم"
👤استیون_هاوکینگ
8 ژانویه زادروز استیون هاوکینگ، نابغه فیزیک بریتانیایی
🆔: @partohair
👤استیون_هاوکینگ
8 ژانویه زادروز استیون هاوکینگ، نابغه فیزیک بریتانیایی
🆔: @partohair